Cargando…
COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments
The effect of immunosuppressant treatments on the incidence of coronavirus disease (COVID-19) remains largely unknown. We studied the association between the pre-exposure to disease-modifying antirheumatic drugs (DMARDs) that decrease immunological responses and the incidence of COVID-19 to explore...
Autores principales: | Soldevila-Domenech, Natalia, Tío, Laura, Llorente-Onaindia, Jone, Martín-García, Elena, Nebot, Pau, de la Torre, Rafael, Gurt, Alba, Maldonado, Rafael, Monfort, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845571/ https://www.ncbi.nlm.nih.gov/pubmed/33519443 http://dx.doi.org/10.3389/fphar.2020.583260 |
Ejemplares similares
-
Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions
por: Blanch-Rubió, Josep, et al.
Publicado: (2020) -
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain
por: La Porta, Carmen, et al.
Publicado: (2015) -
Vaccines – beliefs and concerns: the voice of patients with inflammatory immunomediated diseases
por: Abreu, Cândida, et al.
Publicado: (2023) -
Reumataxi: An experience of solidarity in times of COVID-19()
por: Blanch-Rubió, Josep, et al.
Publicado: (2022) -
Reumataxi: una experiencia solidaria en tiempos de COVID-19
por: Blanch-Rubió, Josep, et al.
Publicado: (2022)